rs17301028

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001080463.2(DYNC2H1):​c.21C>T​(p.Asp7Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.087 in 1,613,576 control chromosomes in the GnomAD database, including 7,044 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.065 ( 436 hom., cov: 32)
Exomes 𝑓: 0.089 ( 6608 hom. )

Consequence

DYNC2H1
NM_001080463.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.28

Publications

14 publications found
Variant links:
Genes affected
DYNC2H1 (HGNC:2962): (dynein cytoplasmic 2 heavy chain 1) This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
DYNC2H1 Gene-Disease associations (from GenCC):
  • asphyxiating thoracic dystrophy 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
  • Jeune syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Majewski type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short rib-polydactyly syndrome, Verma-Naumoff type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 11-103109595-C-T is Benign according to our data. Variant chr11-103109595-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 301995.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.28 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0932 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYNC2H1NM_001080463.2 linkc.21C>T p.Asp7Asp synonymous_variant Exon 1 of 90 ENST00000650373.2 NP_001073932.1
DYNC2H1NM_001377.3 linkc.21C>T p.Asp7Asp synonymous_variant Exon 1 of 89 ENST00000375735.7 NP_001368.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DYNC2H1ENST00000650373.2 linkc.21C>T p.Asp7Asp synonymous_variant Exon 1 of 90 NM_001080463.2 ENSP00000497174.1
DYNC2H1ENST00000375735.7 linkc.21C>T p.Asp7Asp synonymous_variant Exon 1 of 89 1 NM_001377.3 ENSP00000364887.2

Frequencies

GnomAD3 genomes
AF:
0.0654
AC:
9955
AN:
152128
Hom.:
435
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0191
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0709
Gnomad ASJ
AF:
0.136
Gnomad EAS
AF:
0.000769
Gnomad SAS
AF:
0.0849
Gnomad FIN
AF:
0.0459
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0951
Gnomad OTH
AF:
0.0753
GnomAD2 exomes
AF:
0.0736
AC:
18308
AN:
248748
AF XY:
0.0776
show subpopulations
Gnomad AFR exome
AF:
0.0146
Gnomad AMR exome
AF:
0.0484
Gnomad ASJ exome
AF:
0.129
Gnomad EAS exome
AF:
0.000223
Gnomad FIN exome
AF:
0.0444
Gnomad NFE exome
AF:
0.0960
Gnomad OTH exome
AF:
0.0833
GnomAD4 exome
AF:
0.0892
AC:
130393
AN:
1461330
Hom.:
6608
Cov.:
31
AF XY:
0.0897
AC XY:
65213
AN XY:
726904
show subpopulations
African (AFR)
AF:
0.0138
AC:
463
AN:
33480
American (AMR)
AF:
0.0520
AC:
2326
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.137
AC:
3571
AN:
26128
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39696
South Asian (SAS)
AF:
0.0944
AC:
8139
AN:
86208
European-Finnish (FIN)
AF:
0.0455
AC:
2429
AN:
53370
Middle Eastern (MID)
AF:
0.127
AC:
733
AN:
5766
European-Non Finnish (NFE)
AF:
0.0967
AC:
107514
AN:
1111612
Other (OTH)
AF:
0.0863
AC:
5209
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
5777
11555
17332
23110
28887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3832
7664
11496
15328
19160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0654
AC:
9958
AN:
152246
Hom.:
436
Cov.:
32
AF XY:
0.0636
AC XY:
4735
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0191
AC:
792
AN:
41560
American (AMR)
AF:
0.0709
AC:
1083
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
472
AN:
3468
East Asian (EAS)
AF:
0.000771
AC:
4
AN:
5188
South Asian (SAS)
AF:
0.0858
AC:
414
AN:
4826
European-Finnish (FIN)
AF:
0.0459
AC:
487
AN:
10602
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0951
AC:
6469
AN:
68006
Other (OTH)
AF:
0.0745
AC:
157
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
490
981
1471
1962
2452
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0876
Hom.:
1102
Bravo
AF:
0.0634
Asia WGS
AF:
0.0280
AC:
100
AN:
3478
EpiCase
AF:
0.0970
EpiControl
AF:
0.102

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Jeune thoracic dystrophy Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Asphyxiating thoracic dystrophy 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
11
DANN
Benign
0.89
PhyloP100
2.3
PromoterAI
0.0064
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17301028; hg19: chr11-102980324; COSMIC: COSV107392413; API